Company Profile for Novoste Corporation.Business Editors --(BUSINESS WIRE) Novoste Corporation, based in Atlanta, Georgia, develops advanced medical treatments for coronary and vascular diseases vascular diseases, n.pl diseases of the peripheral circulatory system. and is the worldwide leader in vascular vascular /vas·cu·lar/ (vas´ku-ler) 1. pertaining to vessels, particularly blood vessels. 2. indicative of a copious blood supply. vas·cu·lar adj. brachytherapy brachytherapy /brachy·ther·a·py/ (-ther´ah-pe) treatment with ionizing radiation whose source is applied to the surface of the body or within the body a short distance from the area being treated. . The Company's Beta-Cath(TM) System is commercially available in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , as well as in the European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the European Community and several other countries.
Company: Novoste Corporation
Headquarters Address: 3890 Steve Reynolds Blvd.
Norcross, Georgia 30093
Main Telephone: (770) 717-0904
Website: www.novoste.com
Ticker: NOVT(NASDAQ)
Type of Organization: Public
Industry: Health: Medical Devices
Earnings Release Dates: 1st Quarter: April 21, 2003
Key Executives: CEO: Al Novak
CFO: Ed Cordell
Investor Relations
Contact: Sheila Lovern
Phone: (770) 810-3149
Email: slovern@novoste.com
|
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion